CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Lexicon Pharmaceuticals Fiscal Q4 2023 Earnings Report - CapyFin

Lexicon Pharmaceuticals

LXRX · NASDAQ🇺🇸

Overview Earnings

Dividends Seasonality Metrics

Q3 2025 +2.96%Q2 2025 +10.78%Q1 2025 +3.13%Q4 2024 +6.55%Q3 2024 -14.17%Q2 2024 -24.44%Q1 2024 +5.45%Q4 2023 +16.13%Q3 2023 -17.20%Q2 2023 -1.06%Q1 2023 +12.30%Q4 2022 +21.82%Q3 2022 +8.74%Q2 2022 +13.50%Q1 2022 -7.22%Q4 2021 -25.96%Q3 2021 -11.25%Q2 2021 +1.96%Q1 2021 -0.43%Q4 2020 -1.42%Q3 2020 -9.02%Q2 2020 +11.49%Q1 2020 +3.41%Q4 2019 -10.57%Q3 2019 -8.57%Q2 2019 -21.08%Q1 2019 +4.66%Q4 2018 +2.23%Q3 2018 +8.43%Q2 2018 -3.00%Q1 2018 +8.43%Q4 2017 +1.35%Q3 2017 -6.32%Q2 2017 -4.42%Q1 2017 +2.43%Q4 2016 +9.02%Q3 2016 -4.25%Q2 2016 +1.55%Q1 2016 -15.65%Q4 2015 +24.41%Q3 2015 +30.55%Q2 2015 -8.62%Q1 2015 -5.66%Q4 2014 +14.29%Q3 2014 +2.11%Q2 2014 -6.63%Q1 2014 +1.43%Q4 2013 +3.85%Q3 2013 -2.61%Q2 2013 +7.83%Q1 2013 +2.53%Q4 2012 +1.88%Q3 2012 -9.57%Q2 2012 +3.67%Q1 2012 +1.32%Q4 2011 +5.56%Q3 2011 -9.92%Q2 2011 -7.14%Q1 2011 +1.86%Q4 2010 +6.32%Q3 2010 -3.68%Q2 2010 -0.66%Q1 2010 +8.03%

Mar 11, 2024

•

Dec 31, 2023

Lexicon Pharmaceuticals Q4 2023 Earnings Report

Previous year: $28K

Previous year: -$0.16

Previous year: $14M

Previous year: $16.3M

Previous year: -$75K

Cash and Equivalents

Previous year: $138M

Previous year: -$22.8M

Previous year: $194M

Lexicon Pharmaceuticals

Unlock previous datapoints

Lexicon Pharmaceuticals

Unlock previous datapoints

Revenue by Segment

Net Product Revenue

CapyFin.com

Royalties and Other Revenue

Unlock previous datapoints

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View Lexicon Pharmaceuticals

Lexicon Pharmaceuticals Revenue by Segment